Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction: Results of the EXCELLENT Trial.

Roncalli J, Roubille F, Cottin Y, Leroux L, Mathur A, Irving J, Khan SQ, Meneveau N, Bresson D, Hovasse T, Pompilio G, Matta A, Henon P, Trebuchet G, de Kalbermatten M, Garitaonandia I, Saloux E, Manrique A, Meyer N, Marie PY, Bhatt DL, Solomon SD, Montalescot G, Newby DE, Zannad F, EXCELLENT Trial Investigators

Open source

DOI: 10.1016/j.jchf.2025.102626
Published: 2025 Nov
Container: JACC. Heart failure
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jchf.2025.102626,
  title = {Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction: Results of the EXCELLENT Trial.},
  author = {Roncalli J and Roubille F and Cottin Y and Leroux L and Mathur A and Irving J and Khan SQ and Meneveau N and Bresson D and Hovasse T and Pompilio G and Matta A and Henon P and Trebuchet G and de Kalbermatten M and Garitaonandia I and Saloux E and Manrique A and Meyer N and Marie PY and Bhatt DL and Solomon SD and Montalescot G and Newby DE and Zannad F and EXCELLENT Trial Investigators},
  year = {2025},
  journal = {JACC. Heart failure},
  doi = {10.1016/j.jchf.2025.102626},
  url = {https://doi.org/10.1016/j.jchf.2025.102626}
}

RIS

TY  - JOUR
TI  - Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction: Results of the EXCELLENT Trial.
AU  - Roncalli J
AU  - Roubille F
AU  - Cottin Y
AU  - Leroux L
AU  - Mathur A
AU  - Irving J
AU  - Khan SQ
AU  - Meneveau N
AU  - Bresson D
AU  - Hovasse T
AU  - Pompilio G
AU  - Matta A
AU  - Henon P
AU  - Trebuchet G
AU  - de Kalbermatten M
AU  - Garitaonandia I
AU  - Saloux E
AU  - Manrique A
AU  - Meyer N
AU  - Marie PY
AU  - Bhatt DL
AU  - Solomon SD
AU  - Montalescot G
AU  - Newby DE
AU  - Zannad F
AU  - EXCELLENT Trial Investigators
PY  - 2025
JO  - JACC. Heart failure
DO  - 10.1016/j.jchf.2025.102626
UR  - https://doi.org/10.1016/j.jchf.2025.102626
ER  -

APA

J, R., F, R., Y, C., L, L., A, M., J, I., SQ, K., N, M., D, B., T, H., G, P., A, M., P, H., G, T., M, D. K., I, G., E, S., A, M., N, M., PY, M., DL, B., SD, S., G, M., DE, N., F, Z., & Investigators, E. T. (2025). Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction: Results of the EXCELLENT Trial.. JACC. Heart failure. https://doi.org/10.1016/j.jchf.2025.102626

Source records

pubmed · retrieved 2026-09-26T18:22:02.301Z